Investor Relations

Corporate Profile

Great Elm Capital Corp. is an externally-managed business development company that invests in the debt instruments of middle market companies with a focus on catalyst-driven opportunities. We elected to be regulated as a business development company, or BDC, under the Investment Company Act of 1940, as amended. Our stock is traded on NASDAQ under the ticker symbol “GECC”.

Price

Change

Volume

Events & Presentations

All Events & Presentations

News Releases

June 17, 2021

Summary Toggle Great Elm Capital Corp. Prices Public Offering of $50,000,000 of 5.875% Notes Due 2026

WALTHAM, Mass. , June 17, 2021 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today the pricing of its underwritten public offering of $50,000,000 aggregate principal amount of its 5.875% notes due 2026 (the “Notes”), which will result in net proceeds

PDF Version
June 16, 2021

Summary Toggle Great Elm Capital Corp. Announces Public Offering of Unsecured Notes

WALTHAM, Mass. , June 16, 2021 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today the commencement of an underwritten public offering of unsecured notes due 2026 (the “Notes”). The Notes are expected to be listed on The Nasdaq Global Market under

PDF Version
May 21, 2021

Summary Toggle Great Elm Capital Corp. Announces Record and Payment Dates for Second Quarter 2021 Quarterly Cash Distribution of $0.10 Per Share

WALTHAM, Mass. , May 21, 2021 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” or “GECC,”) (NASDAQ: GECC), a business development company, today announced that its second quarter 2021 distribution of $0.10 per share in cash is payable on June 30, 2021 to stockholders of record as of

PDF Version

All Press Releases

Investor Relations

Corporate Profile

Events & Presentations

Great Elm Capital Corp. First Quarter 2021 Financial Results

Great Elm Capital Corp. Q1 2021 Earnings Presentation

News Releases

Featured Documents